The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Mechanism of plasmid-mediated quinolone resistance
Open accessAbstract
Quinolones are potent antibacterial agents that specifically target bacterial DNA gyrase and topoisomerase IV. Widespread use of these agents has contributed to the rise of bacterial quinolone resistance. Previous studies have shown that quinolone resistance arises by mutations in chromosomal genes. Recently, a multiresistance plasmid was discovered that encodes transferable resistance to quinolones. We have cloned the plasmid-quinolone resistance gene, termed qnr, and found it in an integron-like environment upstream from qacE Δ 1 and sulI . The gene product Qnr was a 218-aa protein belonging to the pentapeptide repeat family and shared sequence homology with the immunity protein McbG, which is thought to protect DNA gyrase from the action of microcin B17. Qnr had pentapeptide repeat domains of 11 and 28 tandem copies, separated by a single glycine with a consensus sequence of A/C D/N L/F X X. Because the primary target of quinolones is DNA gyrase in Gram-negative strains, we tested the ability of Qnr to reverse the inhibition of gyrase activity by quinolones. Purified Qnr-His 6 protected Escherichia coli DNA gyrase from inhibition by ciprofloxacin. Gyrase protection was proportional to the concentration of Qnr-His 6 and inversely proportional to the concentration of ciprofloxacin. The protective activity of Qnr-His 6 was lost by boiling the protein and involved neither quinolone inactivation nor independent gyrase activity. Protection of topoisomerase IV, a secondary target of quinolone action in E. coli , was not evident. How Qnr protects DNA gyrase and the prevalence of this resistance mechanism in clinical isolates remains to be determined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
Quinolone resistance from a transferable plasmid
Martínez-Martínez, L., Pascual, A., & Jacoby, G. A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07322-4 · Cited by 1,100
Self-citationMobile gene cassettes and integrons: capture and spread of genes by site‐specific recombination
Hall, R. M., & Collis, C. M. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02368.x · Cited by 774
A structural basis of the interactions between leucine-rich repeats and protein ligands
Kobe, B., & Deisenhofer, J. (1995) · Nature · doi:10.1038/374183a0 · Cited by 727
Photonic detection of bacterial pathogens in living hosts
Contag, C. H., Contag, P. R., Mullins, J. I., Spilman, S. D., Stevenson, D. K., & Benaron, D. A. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.mmi_18040593.x · Cited by 652
Emerging Mechanisms of Fluoroquinolone Resistance
Hooper, D. C. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010239 · Cited by 633
Efflux-Mediated Resistance to Fluoroquinolones in Gram-Negative Bacteria
Poole, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2233-2241.2000 · Cited by 371
Paulsen, I. T., Littlejohn, T. G., Rådström, P., Sundström, L., Sköld, O., Swedberg, G., & Skurray, R. A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.4.761 · Cited by 320
Jacoby, G. A., & Han, P. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.4.908-911.1996 · Cited by 295
Self-citationPeng, H., & Marians, K. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80551-1 · Cited by 261
Cited by
Persister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052
“The plasmid-coded Qnr (Quinolone resistance) proteins confer relatively low-level (but clinically significant) resistance to fluoroquinolone”
BackgroundMolecular Mechanisms of Antibacterial Multidrug Resistance
Alekshun, M. N., & Levy, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.03.004 · Cited by 1,647
Sampling the Antibiotic Resistome
D'Costa, V. M., McGrann, K. M., Hughes, D. W., & Wright, G. D. (2006) · Science · doi:10.1126/science.1120800 · Cited by 1,594
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282
Global Challenge of Multidrug-Resistant Acinetobacter baumannii
Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., & Bonomo, R. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01464-06 · Cited by 1,139
Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success
Redgrave, L. S., Sutton, S. B., Webber, M. A., & Piddock, L. J. V. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.04.007 · Cited by 1,008
The worldwide emergence of plasmid-mediated quinolone resistance
Robicsek, A., Jacoby, G. A., & Hooper, D. C. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70599-0 · Cited by 966
Self-citationPlasmid-Mediated Quinolone Resistance: a Multifaceted Threat
Strahilevitz, J., Jacoby, G. A., Hooper, D. C., & Robicsek, A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-09 · Cited by 928
Self-citationMechanisms of Resistance to Quinolones
Jacoby, G. A. (2005) · Clinical Infectious Diseases · doi:10.1086/428052 · Cited by 924
Self-citationResistance in Gram-Negative Bacteria: Enterobacteriaceae
Paterson, D. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.013 · Cited by 874
Multidrug Tolerance of Biofilms and Persister Cells
Lewis, K. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-75418-3_6 · Cited by 804
Pham, T. D. M., Ziora, Z. M., & Blaskovich, M. A. T. (2019) · MedChemComm · doi:10.1039/c9md00120d · Cited by 785
Bacterial Topoisomerase Inhibitors: Quinolone and Pyridone Antibacterial Agents
Mitscher, L. A. (2005) · Chemical Reviews · doi:10.1021/cr030101q · Cited by 781
Prevalence in the United States of aac(6 ′ ) - Ib - cr Encoding a Ciprofloxacin-Modifying Enzyme
Park, C. H., Robicsek, A., Jacoby, G. A., Sahm, D., & Hooper, D. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00915-06 · Cited by 757
Self-citationMechanisms of drug resistance: quinolone resistance
Hooper, D. C., & Jacoby, G. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12830 · Cited by 716
Self-citationRuiz, J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg222 · Cited by 711
The role of antibiotics and antibiotic resistance in nature
Aminov, R. I. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.01972.x · Cited by 687
Persisters: a distinct physiological state of E. coli
Shah, D., Zhang, Z., Khodursky, A. B., Kaldalu, N., Kurg, K., & Lewis, K. (2006) · BMC Microbiology · doi:10.1186/1471-2180-6-53 · Cited by 629
Exploiting bacterial DNA gyrase as a drug target: current state and perspectives
Collin, F., Karkare, S., & Maxwell, A. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3557-z · Cited by 606
Quinolones: from antibiotics to autoinducers
Heeb, S., Fletcher, M. P., Chhabra, S. R., Diggle, S. P., Williams, P., & Cámara, M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2010.00247.x · Cited by 595
qnr Prevalence in Ceftazidime-Resistant Enterobacteriaceae Isolates from the United States
Robicsek, A., Strahilevitz, J., Sahm, D. F., Jacoby, G. A., & Hooper, D. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01647-05 · Cited by 569
Self-citationKristiansson, E., Fick, J., Janzon, A., Grabic, R., Rutgersson, C., Weijdegård, B., Söderström, H., & Larsson, D. G. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017038 · Cited by 566
Mechanisms of quinolone resistance in Escherichia coli and Salmonella: Recent developments
Hopkins, K. L., Davies, R. H., & Threlfall, E. J. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.02.006 · Cited by 557
Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance
Hooper, D. C., & Jacoby, G. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025320 · Cited by 553
Self-citationResistance in gram-negative bacteria: Enterobacteriaceae
Paterson, D. L. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.238 · Cited by 535
Evolution and ecology of antibiotic resistance genes
Aminov, R. I., & Mackie, R. I. (2007) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2007.00757.x · Cited by 510
DNA topoisomerases: harnessing and constraining energy to govern chromosome topology
Schoeffler, A. J., & Berger, J. M. (2008) · Quarterly Reviews of Biophysics · doi:10.1017/s003358350800468x · Cited by 490
Mechanism of action of and resistance to quinolones
Fàbrega, A., Madurga, S., Giralt, E., & Vila, J. (2009) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2008.00063.x · Cited by 482
Plasmid-Mediated Quinolone Resistance
Jacoby, G. A., Strahilevitz, J., & Hooper, D. C. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.plas-0006-2013 · Cited by 479
Self-citationYamane, K., Wachino, J.-I., Suzuki, S., Kimura, K., Shibata, N., Kato, H., Shibayama, K., Konda, T., & Arakawa, Y. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00339-07 · Cited by 467
Plasmid-Mediated Quinolone Resistance in Clinical Isolates of Escherichia coli from Shanghai, China
Wang, M., Tran, J. H., Jacoby, G. A., Zhang, Y., Wang, F., & Hooper, D. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2242-2248.2003 · Cited by 467
Self-citationEmergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae
Nordmann, P., & Poirel, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki245 · Cited by 425
Resistance integrons and super-integrons
Fluit, A. C., & Schmitz, F.-J. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1198-743x.2004.00858.x · Cited by 419
qnrB , Another Plasmid-Mediated Gene for Quinolone Resistance
Jacoby, G. A., Walsh, K. E., Mills, D. M., Walker, V. J., Oh, H., Robicsek, A., & Hooper, D. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1178-1182.2006 · Cited by 400
Self-citationOrigin of Plasmid-Mediated Quinolone Resistance Determinant QnrA
Poirel, L., Rodriguez-Martinez, J.-M., Mammeri, H., Liard, A., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3523-3525.2005 · Cited by 394
Quinolones: Action and Resistance Updated
Drlica, K., Hiasa, H., Kerns, R., Malik, M., Mustaev, A., & Zhao, X. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789630947 · Cited by 376
Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use
Dalhoff, A. (2012) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2012/976273 · Cited by 354
Van Bambeke, F., Michot, J.-M., Van Eldere, J., & Tulkens, P. M. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01131.x · Cited by 342
Wang, M., Guo, Q., Xu, X., Wang, X., Ye, X., Wu, S., Hooper, D. C., & Wang, M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01400-08 · Cited by 324
Fluoroquinolones: Action and Resistance
Drlica, K., & Malik, M. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452537 · Cited by 317
Plasmid-mediated quinolone resistance: an update
Rodríguez-Martínez, J. M., Velasco, C., Pascual, Á., Cano, M. E., Martínez-Martínez, L., Martínez-Martínez, L., & Pascual, Á. (2011) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0120-2 · Cited by 306
History of antimicrobial drug discovery: Major classes and health impact
Aminov, R. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.10.001 · Cited by 296
A Fluoroquinolone Resistance Protein from Mycobacterium tuberculosis That Mimics DNA
Hegde, S. S., Vetting, M. W., Roderick, S. L., Mitchenall, L. A., Maxwell, A., Takiff, H. E., & Blanchard, J. S. (2005) · Science · doi:10.1126/science.1110699 · Cited by 291
Cloning of a Novel Gene for Quinolone Resistance from a Transferable Plasmid in Shigella flexneri 2b
Hata, M., Suzuki, M., Matsumoto, M., Takahashi, M., Sato, K., Ibe, S., & Sakae, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.801-803.2005 · Cited by 287
Interaction of the Plasmid-Encoded Quinolone Resistance Protein Qnr with Escherichia coli DNA Gyrase
Tran, J. H., Jacoby, G. A., & Hooper, D. C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.118-125.2005 · Cited by 283
Self-citationWhat Antimicrobial Resistance Has Taught Us About Horizontal Gene Transfer
Barlow, M. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-853-9_23 · Cited by 282
Leverstein‐van Hall, M. A., M. Blok, H. E., T. Donders, A. R., Paauw, A., Fluit, A. C., & Verhoef, J. (2003) · The Journal of Infectious Diseases · doi:10.1086/345880 · Cited by 281
Ferreira da Silva, M., Vaz-Moreira, I., Gonzalez-Pajuelo, M., Nunes, O. C., & Manaia, C. M. (2007) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2006.00268.x · Cited by 269
Emergence of Plasmid-Mediated Quinolone Resistance in Escherichia coli in Europe
Mammeri, H., Van De Loo, M., Poirel, L., Martinez-Martinez, L., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.71-76.2005 · Cited by 261
Plasmid-Mediated qepA Gene among Escherichia coli Clinical Isolates from Japan
Yamane, K., Wachino, J.-I., Suzuki, S., & Arakawa, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01137-07 · Cited by 253
Lopatkin, A. J., Sysoeva, T. A., & You, L. (2016) · BioEssays · doi:10.1002/bies.201600133 · Cited by 83
Metadata
- Authors
- Tran, J. H., & Jacoby, G. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-04-09
- Volume
- 99
- Issue
- 8
- Pages
- 5638-5642
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2160308376
- Cited by
- 564
- References
- 23
- FWCI
- 10.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.